Product News

Share this article:

Wyeth received FDA approval for a new indication on Tygacil, a pneumonia drug. The additional indication was approved for adult patients with community-acquired bacterial pneumonia.

 

A New York federal judge has asked the FDA to make Plan B, an emergency contraceptive, available to 17-year-olds within 30 days. US District Judge Edward Korman also asked the agency to review whether to make the product available for girls of all ages, without a prescription. Plan B is manufactured by Barr Pharmaceuticals, a division of Teva Pharmaceuticals.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters